The Current Ratio as of September 2024 (TTM) for MaxCyte, Inc. (MXCT) is 14.31

According to MaxCyte, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.31. This represents a change of 12.03% compared to the average of 12.77 of the last 4 quarters.

MaxCyte, Inc. (MXCT) Historical Current Ratio (quarterly & annually)

How has MXCT Current Ratio performed in the past?

The mean historical Current Ratio of MaxCyte, Inc. over the last ten years is 6.39. The current 14.31 Current Ratio has changed 22.30% with respect to the historical average. Over the past ten years (40 quarters), MXCT's Current Ratio was at its highest in in the September 2021 quarter at 21.43. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

MaxCyte, Inc. (MXCT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of MaxCyte, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MaxCyte, Inc. (MXCT) Average Current Ratio

How has MXCT Current Ratio performed in the past?

The current Current Ratio of MaxCyte, Inc. (MXCT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MaxCyte, Inc. (MXCT) Current Ratio vs. Peers

How is MXCT’s Current Ratio compared to its peers?

MaxCyte, Inc.’s Current Ratio is greater than Sight Sciences, Inc. (11.01), greater than CVRx, Inc. (10.08), greater than NeuroPace, Inc. (6.37), greater than Rapid Micro Biosystems, Inc. (5.92), greater than CONMED Corporation (2.34), greater than OrthoPediatrics Corp. (4.90), greater than Surmodics, Inc. (3.98), greater than Integer Holdings Corporation (3.29), greater than Pulmonx Corporation (8.96), greater than IRadimed Corporation (9.87), greater than Orthofix Medical Inc. (2.48), greater than ProSomnus, Inc. Common Stock (0.30), greater than Anika Therapeutics, Inc. (5.93), greater than Heska Corporation (5.64),

Build a custom stock screener for MaxCyte, Inc. (MXCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MaxCyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MaxCyte, Inc. (MXCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MaxCyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.